Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Brazil Approves Pfizer/BioNTech COVID-19 Vaccine For Children 12-15 Years Old

06/11/2021 | 09:47am EDT


© MT Newswires 2021
All news about BIONTECH SE
11:14aEuropean ADRs Move Higher in Monday Trading
MT
10:48aBIONTECH : Berenberg Bank Adjusts BioNTech PT to $400 From $235, Maintains Buy R..
MT
10:02aBIONTECH : Corporate Presentation August 1 2021
PU
10:02aBIONTECH : Corporate Presentation
PU
07:00aBIONTECH : to Report Second Quarter Financial Results and Operational Update on ..
AQ
07:00aPRESS RELEASE : BioNTech to Report Second Quarter Financial Results and Operatio..
DJ
06:06aPFIZER : Should I Get the Covid-19 Vaccine While Pregnant or Breastfeeding? Expe..
AQ
08/01MARKET CHATTER : Pfizer, Moderna Raise COVID-19 Vaccine Prices in EU Supply Cont..
MT
07/31MODERNA : U.S. CDC Says Delivered 400,675,525 Doses Of COVID-19 Vaccine As Of Ju..
RE
07/30MODERNA : Most COVID-19 cases in Massachusetts outbreak among vaccinated, says C..
RE
More news
Financials
Sales 2021 12 716 M 15 095 M 15 095 M
Net income 2021 7 363 M 8 740 M 8 740 M
Net cash 2021 8 242 M 9 784 M 9 784 M
P/E ratio 2021 9,77x
Yield 2021 -
Capitalization 69 202 M 82 168 M 82 148 M
EV / Sales 2021 4,79x
EV / Sales 2022 5,20x
Nbr of Employees 2 200
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Last Close Price 286,52 €
Average target price 165,00 €
Spread / Average Target -42,4%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE317.33%79 303
GILEAD SCIENCES, INC.17.22%85 648
WUXI APPTEC CO., LTD.36.10%59 516
REGENERON PHARMACEUTICALS18.94%59 505
VERTEX PHARMACEUTICALS-14.71%52 296
GENMAB A/S15.10%29 546